Dr. Valentina Hayashi

Oncology pharmacist · Hospital Clínic Barcelona · Spain (ES) · Oncology

Tier 2STK-0002GoodOwner MSL RARachel Adeyemi

Data minimisation

Consent status: Recorded. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Thoracic oncology
Disease interests: NSCLC, SCLC
Scientific interests: irAE managementElderly patientsPD-L1 biomarkers
Engagement preference: Virtual
Advisory boards: 1
Publications: 11
Source system: Veeva CRM
Data quality: Good

Engagement plan

Cadence target for Tier 2: 2 per year (assumption)

Last engaged: 24 Jun 2026 (83 days ago)
Next planned contact: 24 Dec 2026
Last 6 months vs target: 100%
2 of 1 expected engagements

Insights from this stakeholder (2)

INS-0017Chemotherapy-free first line
25 Jun 2026 · Evidence gap
HighDeduplicated
INS-0009Elderly / ECOG 2 patients
01 May 2026 · Product understanding
HighClosed

Engagement history (2)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
24 Jun 2026	Congress meeting	Virtual	Rachel Adeyemi	Vantrexa	Chemotherapy-free first line	1	—	Reviewed	ENG-0017
30 Apr 2026	Scientific exchange	Phone	Rachel Adeyemi	Vantrexa	Elderly / ECOG 2 patientsDuration of response	1	—	Reviewed	ENG-0036

Timeline

24 Jun 2026
Congress meeting
Chemotherapy-free first line
30 Apr 2026
Scientific exchange
Elderly / ECOG 2 patients, Duration of response

Related stakeholders (7)

Hospital Clínic Barcelona

Dr. Rosa Bauer
Radiation oncologist
Tier 1
Dr. Noor Abbott
Oncology pharmacist
Tier 2
Dr. Hiroshi Xu
Radiation oncologist
Tier 2
Dr. Benedikt Rossi
Primary care physician
Tier 3
Dr. Quentin Abbott
General neurologist
Tier 2
Dr. Chloé Ivanova
Headache specialist
Tier 1
Dr. Ingrid Bauer
General neurologist
Tier 1